GLP-1 drugs, such as Ozempic and Wegovy, have become increasingly common alternatives for the treatment of type 2 diabetes and weight loss. However, new research from Rutgers University in the United States suggests that their effects could go beyond metabolic health and also influence certain behaviors associated with violence.The study, published in the scientific journal Criminology, analyzed whether GLP-1 receptor agonists are related to cha…
GLP-1 drugs, such as Ozempic and Wegovy, have become increasingly common alternatives for the treatment of type 2 diabetes and weight loss. However, new research from Rutgers University in the United States suggests that their effects could go beyond metabolic health and also influence certain behaviors associated with violence.The study, published in the scientific journal Criminology, analyzed whether GLP-1 receptor agonists are related to cha…